Coronary centerline overlap
0.93 overlap coefficient
- EndpointCenterline overlap against manual reference
- Population80 CCTA cases with three-observer manual reference annotations
- Tested versionAV Cardiac CT configuration cleared in K260169
FDA-cleared profile
Philips Medical Systems Nederland B.V. · CT/CTA · FDA-cleared (510(k))
Authorized purpose: AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac function, to prepare cardiac interventions; physician review and decisions remain required.
Evidence takeaway. Evidence from the reviewed source record: The K260169 technical study used 80 CCTA cases and three observers' manual reference annotations. It measures algorithm agreement and labeling performance rather than clinical diagnostic or treatment outcomes.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Major-vessel-label sensitivity in the technical CCTA performance evaluation, not diagnostic sensitivity for coronary artery disease.
No disease-detection specificity was established by the reviewed technical-performance summary.
0.93 overlap coefficient
91 percent
K260169
Endpoints include coronary centerline, label and lumen-segmentation agreement. The study is not an autonomous diagnosis or clinical-outcome study.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Gated conventional or spectral cardiac CT data, including coronary CT angiography datasets.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-06 · FDA 510(k) K260169: AV Cardiac CT
Source context, not route validation: The current AVW V15.1.3 DICOM conformance statement lists AV Cardiac CT as an integrated component and describes DICOM image exchange features.
Scope: Product family. Later AVW V15.1.3 documentation; it does not establish the exact K260169 installed release or interfaces.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-06 · DICOM Conformance Statement: Advanced Visualization Workspace V15.1.3
Source context, not route validation: Standalone software-only medical device.
Scope: Exact FDA submission. The summary does not establish a complete current hosting or network architecture.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-06 · FDA 510(k) K260169: AV Cardiac CT
Source context, not route validation: Chamber and aortic-root segmentations, coronary centerlines/labels/lumen/wall information, user-defined stenosis and plaque findings, cardiac-function analysis and CAD-RADS 2.0 reporting based on user-confirmed findings.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-06 · FDA 510(k) K260169: AV Cardiac CT
Unresolved route: Chamber and aortic-root segmentations, coronary centerlines/labels/lumen/wall information, user-defined stenosis and plaque findings, cardiac-function analysis and CAD-RADS 2.0 reporting based on user-confirmed findings.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-06 · FDA 510(k) K260169: AV Cardiac CT
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The summary does not establish a complete current hosting or network architecture.
Later AVW V15.1.3 documentation; it does not establish the exact K260169 installed release or interfaces.
Vendor statement, not an attestation. Identity bridge: the statement is on philips.com (Royal Philips) and covers Philips products and services; the FDA applicant entity appears in Philips' own BCR members list on documents.philips.com (Philips Ultrasound LLC, Philips Medical Systems Nederland B.V., Philips Healthcare (Suzhou), Philips Medical Systems DMC GmbH, Philips Medical Systems Technologies Ltd., Philips Oy). Corporate policy; exact-release scope is not established.
Vendor statement, not an attestation. The policy names Philips generally and does not scope these commitments to any specific product release; exact-release scope is not established.
Philips' AVW V15.1.3 DICOM conformance statement lists AV Cardiac CT within the AV Cardio Vascular Suite and describes receiving, storing, querying and exchanging DICOM images.
product family · checked 2026-09-06This is current product-family documentation, not exact evidence for the K260169 configuration.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
Stored PubMed and ClinicalTrials candidate metadata snapshots were screened; both arrays were empty. No candidate evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, vendor documentation, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public exact-version price or procurement record reviewed.
Bounded web search on 2026-10-26 (query: "Philips Advanced Visualization cardiac CT reimbursement"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. A Philips reimbursement guide that surfaced was read; it covers interventional procedures and does not name this product. This records what was found, not that none exists.
Qualified-user intent does not establish a verified current training program.
8 sources - 3 history items
Scope: identity, clinicalUse, modality, anatomy, implementationCapabilities, evidenceStudies, reportedSensitivity
Scope: regulatoryIdentity, modalityContext
Scope: intendedUsers, careSetting, output, evidenceSummary, anatomy, evidenceStudies
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: productFamily, implementationCapabilities
Scope: security
Regulatory record
510(k)
Research record
human reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Siemens Medical Solutions USA, Inc.
Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.
Keya Medical Technology Co., Ltd.
Authorized purpose: Coronary plaque and stenosis quantification from CCTA
Canon Medical Informatics, Inc.
Authorized purpose: CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and highlighted calcium segmentation for qualified clinical review.
Circle Cardiovascular Imaging, Inc.
Authorized purpose: cvi42 Coronary Plaque supports qualified professionals with viewing, post-processing, and qualitative and quantitative evaluation of adult cardiac CT DICOM images to assess the presence and extent of coronary plaques and stenoses in CCTA for CAD or suspected CAD.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history